Results 201 to 210 of about 4,747,249 (340)

Phytonanoparticles as novel drug carriers for enhanced osteogenesis and osseointegration. [PDF]

Discov Nano
Suresh N, Thomas NG, Mauramo M, Waltimo T, Sorsa T, Anil S.   +5 more
europepmc   +1 more source

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola de Candia, Giuseppe Matarese   +19 more
wiley   +1 more source

Dual-Functioning Metal-Organic Frameworks: Methotrexate-Loaded Gadolinium MOFs as Drug Carriers and Radiosensitizers. [PDF]

Chemistry
Karaca B, Sakarya D, Siyah P, Senisik AM, Kaptan Y, Çavusoglu FC, Mansuroglu DS, Öztürk S, Bayazit SS, Barlas FB.   +9 more
europepmc   +1 more source

Semifluorinated Alkanes as New Drug Carriers-An Overview of Potential Medical and Clinical Applications. [PDF]

Pharmaceutics, 2023
Tsagogiorgas C, Otto M.
europepmc   +1 more source

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan, María A. Piedrabuena, María A. Zarate, Sofía Rodríguez Murúa, Ezequiel I. Surace, Mauricio F. Farez, Marcela P. Fiol, María C. Ysrraelit, Jorge Correale   +8 more
wiley   +1 more source

Recent Advances in the Application of Hydrogels as Drug Carriers in Inflammatory Bowel Disease: A Review. [PDF]

Int J Mol Sci
Zhang Q, Lv B, Li M, Zhang T, Li H, Tian H, Yu Y.   +6 more
europepmc   +1 more source

Native gastrointestinal mucus: Critical features and techniques for studying interactions with drugs, drug carriers, and bacteria. [PDF]

Adv Drug Deliv Rev, 2023
Wang CM, Fernez MT, Woolston BM, Carrier RL.   +3 more
europepmc   +1 more source

Synthesis and application of PLA/PEG block copolymers as anti-cancer drug carriers [PDF]

, 2006
Jie Pan
openalex   +1 more source

Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Bilateral globus pallidus pars interna deep brain stimulation (GPi‐DBS) is a recognized and effective treatment option for drug‐resistant dystonia patients. However, the clinical GPi‐DBS outcomes vary significantly. Herein, we explored the pre‐implant factors affecting GPi‐DBS effectiveness.
Mahboubeh Ahmadipour, Luigi M. Romito, Antonio E. Elia, Nico Golfré Andreasi, Roberto Eleopra, Alberto Mazzoni, Fabiana Colucci   +6 more
wiley   +1 more source

Numerical Simulation in Microvessels for the Design of Drug Carriers with the Immersed Boundary-Lattice Boltzmann Method. [PDF]

Micromachines (Basel)
Hou Y, Hu M, Sun D, Sun Y.
europepmc   +1 more source